Clinical Trial Update: Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Foxy-5 as neo-adjuvant therapy in subjects with Wnt-5a low colon cancer (colon cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Foxy-5

Snippet

Sponsor: WntResearch AB | Conditions: Colon Cancer | Phase 2 | Status: UNKNOWN